AGENUS INC. Files 8-K: Material Agreement, Equity Sales
Ticker: AGEN · Form: 8-K · Filed: Feb 26, 2025 · CIK: 1098972
Sentiment: neutral
Topics: material-agreement, equity-sale, financial-obligation
TL;DR
AGENUS INC. signed a big deal and sold stock, filing an 8-K on Feb 20, 2025.
AI Summary
On February 20, 2025, AGENUS INC. entered into a material definitive agreement, creating a direct financial obligation. The company also reported on unregistered sales of equity securities and filed financial statements and exhibits. This 8-K filing details these significant corporate events.
Why It Matters
This filing indicates AGENUS INC. has entered into a new financial commitment and has issued equity, which could impact its financial structure and shareholder value.
Risk Assessment
Risk Level: medium — The filing details a material definitive agreement and unregistered equity sales, which can introduce financial obligations and dilution risks.
Key Numbers
- 000-29089 — Commission File Number (Identifies AGENUS INC.'s SEC filings.)
- 06-1562417 — IRS Employer Identification No. (Tax identification for AGENUS INC.)
Key Players & Entities
- AGENUS INC. (company) — Registrant
- February 20, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 000-29089 (filing_number) — Commission File Number
- 06-1562417 (tax_id) — IRS Employer Identification No.
- 3 Forbes Road (address) — Principal Executive Offices
- Lexington (city) — Principal Executive Offices
- Massachusetts (state) — Principal Executive Offices
- 02421 (zip_code) — Principal Executive Offices
- ANTIGENICS INC /DE/ (company) — Former Company Name
FAQ
What type of material definitive agreement did AGENUS INC. enter into?
The filing indicates the entry into a material definitive agreement and the creation of a direct financial obligation, but the specific details of the agreement are not provided in this excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on February 20, 2025.
What are the principal executive offices of AGENUS INC.?
The principal executive offices of AGENUS INC. are located at 3 Forbes Road, Lexington, Massachusetts, 02421.
What was AGENUS INC. formerly known as?
AGENUS INC. was formerly known as ANTIGENICS INC /DE/.
What items are covered in this 8-K filing?
This 8-K filing covers the entry into a material definitive agreement, the creation of a direct financial obligation, unregistered sales of equity securities, and financial statements and exhibits.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 26, 2025 regarding AGENUS INC (AGEN).